- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.73 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x IMP: INOSINIC ACID(Non-covalent)
- 8 x 8KY: {2-chloro-5-[({2-[3-(prop-1-en-2-yl)phenyl]propan-2-yl}carbamoyl)amino]phenoxy}acetic acid(Non-covalent)
8KY.2: 16 residues within 4Å:- Chain A: S.166, A.167, H.168, T.224, M.305, G.306, V.330, E.332
- Chain D: V.46, L.47, P.48, S.357, G.360, Y.361
- Ligands: IMP.1, EDO.7
6 PLIP interactions:4 interactions with chain A, 2 interactions with chain D- Hydrophobic interactions: A:A.167, D:P.48, D:Y.361
- Hydrogen bonds: A:S.166, A:E.332, A:E.332
8KY.12: 16 residues within 4Å:- Chain B: S.166, A.167, H.168, T.224, M.305, G.306, V.330, E.332
- Chain C: V.46, L.47, P.48, S.357, G.360, Y.361
- Ligands: IMP.11, EDO.17
6 PLIP interactions:4 interactions with chain B, 2 interactions with chain C- Hydrophobic interactions: B:A.167, C:P.48, C:Y.361
- Hydrogen bonds: B:S.166, B:E.332, B:E.332
8KY.22: 16 residues within 4Å:- Chain A: V.46, L.47, P.48, S.357, G.360, Y.361
- Chain C: S.166, A.167, H.168, T.224, M.305, G.306, V.330, E.332
- Ligands: IMP.21, EDO.27
6 PLIP interactions:2 interactions with chain A, 4 interactions with chain C- Hydrophobic interactions: A:P.48, A:Y.361, C:A.167
- Hydrogen bonds: C:S.166, C:E.332, C:E.332
8KY.32: 16 residues within 4Å:- Chain B: V.46, L.47, P.48, S.357, G.360, Y.361
- Chain D: S.166, A.167, H.168, T.224, M.305, G.306, V.330, E.332
- Ligands: IMP.31, EDO.37
6 PLIP interactions:2 interactions with chain B, 4 interactions with chain D- Hydrophobic interactions: B:P.48, B:Y.361, D:A.167
- Hydrogen bonds: D:S.166, D:E.332, D:E.332
8KY.42: 16 residues within 4Å:- Chain E: S.166, A.167, H.168, T.224, M.305, G.306, V.330, E.332
- Chain H: V.46, L.47, P.48, S.357, G.360, Y.361
- Ligands: IMP.41, EDO.47
6 PLIP interactions:2 interactions with chain H, 4 interactions with chain E- Hydrophobic interactions: H:P.48, H:Y.361, E:A.167
- Hydrogen bonds: E:S.166, E:E.332, E:E.332
8KY.52: 16 residues within 4Å:- Chain F: S.166, A.167, H.168, T.224, M.305, G.306, V.330, E.332
- Chain G: V.46, L.47, P.48, S.357, G.360, Y.361
- Ligands: IMP.51, EDO.57
6 PLIP interactions:4 interactions with chain F, 2 interactions with chain G- Hydrophobic interactions: F:A.167, G:P.48, G:Y.361
- Hydrogen bonds: F:S.166, F:E.332, F:E.332
8KY.62: 16 residues within 4Å:- Chain E: V.46, L.47, P.48, S.357, G.360, Y.361
- Chain G: S.166, A.167, H.168, T.224, M.305, G.306, V.330, E.332
- Ligands: IMP.61, EDO.67
6 PLIP interactions:4 interactions with chain G, 2 interactions with chain E- Hydrophobic interactions: G:A.167, E:P.48, E:Y.361
- Hydrogen bonds: G:S.166, G:E.332, G:E.332
8KY.72: 16 residues within 4Å:- Chain F: V.46, L.47, P.48, S.357, G.360, Y.361
- Chain H: S.166, A.167, H.168, T.224, M.305, G.306, V.330, E.332
- Ligands: IMP.71, EDO.77
6 PLIP interactions:2 interactions with chain F, 4 interactions with chain H- Hydrophobic interactions: F:P.48, F:Y.361, H:A.167
- Hydrogen bonds: H:S.166, H:E.332, H:E.332
- 8 x K: POTASSIUM ION(Non-covalent)
K.3: 6 residues within 4Å:- Chain A: G.217, G.219, C.222
- Chain D: E.386, S.387, H.388
5 PLIP interactions:2 interactions with chain D, 3 interactions with chain A- Metal complexes: D:E.386, D:S.387, A:G.217, A:G.219, A:C.222
K.13: 6 residues within 4Å:- Chain B: G.217, G.219, C.222
- Chain C: E.386, S.387, H.388
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain C- Metal complexes: B:G.217, B:G.219, B:C.222, C:E.386, C:S.387
K.23: 6 residues within 4Å:- Chain A: E.386, S.387, H.388
- Chain C: G.217, G.219, C.222
5 PLIP interactions:3 interactions with chain C, 2 interactions with chain A- Metal complexes: C:G.217, C:G.219, C:C.222, A:E.386, A:S.387
K.33: 6 residues within 4Å:- Chain B: E.386, S.387, H.388
- Chain D: G.217, G.219, C.222
5 PLIP interactions:3 interactions with chain D, 2 interactions with chain B- Metal complexes: D:G.217, D:G.219, D:C.222, B:E.386, B:S.387
K.43: 6 residues within 4Å:- Chain E: G.217, G.219, C.222
- Chain H: E.386, S.387, H.388
5 PLIP interactions:3 interactions with chain E, 2 interactions with chain H- Metal complexes: E:G.217, E:G.219, E:C.222, H:E.386, H:S.387
K.53: 6 residues within 4Å:- Chain F: G.217, G.219, C.222
- Chain G: E.386, S.387, H.388
5 PLIP interactions:3 interactions with chain F, 2 interactions with chain G- Metal complexes: F:G.217, F:G.219, F:C.222, G:E.386, G:S.387
K.63: 6 residues within 4Å:- Chain E: E.386, S.387, H.388
- Chain G: G.217, G.219, C.222
5 PLIP interactions:3 interactions with chain G, 2 interactions with chain E- Metal complexes: G:G.217, G:G.219, G:C.222, E:E.386, E:S.387
K.73: 6 residues within 4Å:- Chain F: E.386, S.387, H.388
- Chain H: G.217, G.219, C.222
5 PLIP interactions:2 interactions with chain F, 3 interactions with chain H- Metal complexes: F:E.386, F:S.387, H:G.217, H:G.219, H:C.222
- 24 x SO4: SULFATE ION(Non-functional Binders)
SO4.4: 7 residues within 4Å:- Chain A: Y.294, Q.295, R.337
- Chain E: Y.294, Q.295, R.337
- Ligands: SO4.44
Ligand excluded by PLIPSO4.5: 2 residues within 4Å:- Chain A: H.78, R.79
Ligand excluded by PLIPSO4.6: 3 residues within 4Å:- Chain A: I.99, Q.147, R.150
Ligand excluded by PLIPSO4.14: 7 residues within 4Å:- Chain B: Y.294, Q.295, R.337
- Chain F: Y.294, Q.295, R.337
- Ligands: SO4.54
Ligand excluded by PLIPSO4.15: 2 residues within 4Å:- Chain B: H.78, R.79
Ligand excluded by PLIPSO4.16: 3 residues within 4Å:- Chain B: I.99, Q.147, R.150
Ligand excluded by PLIPSO4.24: 7 residues within 4Å:- Chain C: Y.294, Q.295, R.337
- Chain H: Y.294, Q.295, R.337
- Ligands: SO4.74
Ligand excluded by PLIPSO4.25: 2 residues within 4Å:- Chain C: H.78, R.79
Ligand excluded by PLIPSO4.26: 3 residues within 4Å:- Chain C: I.99, Q.147, R.150
Ligand excluded by PLIPSO4.34: 7 residues within 4Å:- Chain D: Y.294, Q.295, R.337
- Chain G: Y.294, Q.295, R.337
- Ligands: SO4.64
Ligand excluded by PLIPSO4.35: 2 residues within 4Å:- Chain D: H.78, R.79
Ligand excluded by PLIPSO4.36: 3 residues within 4Å:- Chain D: I.99, Q.147, R.150
Ligand excluded by PLIPSO4.44: 7 residues within 4Å:- Chain A: Y.294, Q.295, R.337
- Chain E: Y.294, Q.295, R.337
- Ligands: SO4.4
Ligand excluded by PLIPSO4.45: 2 residues within 4Å:- Chain E: H.78, R.79
Ligand excluded by PLIPSO4.46: 3 residues within 4Å:- Chain E: I.99, Q.147, R.150
Ligand excluded by PLIPSO4.54: 7 residues within 4Å:- Chain B: Y.294, Q.295, R.337
- Chain F: Y.294, Q.295, R.337
- Ligands: SO4.14
Ligand excluded by PLIPSO4.55: 2 residues within 4Å:- Chain F: H.78, R.79
Ligand excluded by PLIPSO4.56: 3 residues within 4Å:- Chain F: I.99, Q.147, R.150
Ligand excluded by PLIPSO4.64: 7 residues within 4Å:- Chain D: Y.294, Q.295, R.337
- Chain G: Y.294, Q.295, R.337
- Ligands: SO4.34
Ligand excluded by PLIPSO4.65: 2 residues within 4Å:- Chain G: H.78, R.79
Ligand excluded by PLIPSO4.66: 3 residues within 4Å:- Chain G: I.99, Q.147, R.150
Ligand excluded by PLIPSO4.74: 7 residues within 4Å:- Chain C: Y.294, Q.295, R.337
- Chain H: Y.294, Q.295, R.337
- Ligands: SO4.24
Ligand excluded by PLIPSO4.75: 2 residues within 4Å:- Chain H: H.78, R.79
Ligand excluded by PLIPSO4.76: 3 residues within 4Å:- Chain H: I.99, Q.147, R.150
Ligand excluded by PLIP- 32 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.7: 10 residues within 4Å:- Chain A: A.167, G.215, I.216, G.217, P.218, C.222, T.224
- Chain D: Y.361
- Ligands: IMP.1, 8KY.2
Ligand excluded by PLIPEDO.8: 2 residues within 4Å:- Chain A: R.104, R.108
Ligand excluded by PLIPEDO.9: 1 residues within 4Å:- Chain A: R.86
Ligand excluded by PLIPEDO.10: 4 residues within 4Å:- Chain A: R.297, Y.299, R.337
- Chain D: T.393
Ligand excluded by PLIPEDO.17: 10 residues within 4Å:- Chain B: A.167, G.215, I.216, G.217, P.218, C.222, T.224
- Chain C: Y.361
- Ligands: IMP.11, 8KY.12
Ligand excluded by PLIPEDO.18: 2 residues within 4Å:- Chain B: R.104, R.108
Ligand excluded by PLIPEDO.19: 1 residues within 4Å:- Chain B: R.86
Ligand excluded by PLIPEDO.20: 4 residues within 4Å:- Chain B: R.297, Y.299, R.337
- Chain C: T.393
Ligand excluded by PLIPEDO.27: 10 residues within 4Å:- Chain A: Y.361
- Chain C: A.167, G.215, I.216, G.217, P.218, C.222, T.224
- Ligands: IMP.21, 8KY.22
Ligand excluded by PLIPEDO.28: 2 residues within 4Å:- Chain C: R.104, R.108
Ligand excluded by PLIPEDO.29: 1 residues within 4Å:- Chain C: R.86
Ligand excluded by PLIPEDO.30: 4 residues within 4Å:- Chain A: T.393
- Chain C: R.297, Y.299, R.337
Ligand excluded by PLIPEDO.37: 10 residues within 4Å:- Chain B: Y.361
- Chain D: A.167, G.215, I.216, G.217, P.218, C.222, T.224
- Ligands: IMP.31, 8KY.32
Ligand excluded by PLIPEDO.38: 2 residues within 4Å:- Chain D: R.104, R.108
Ligand excluded by PLIPEDO.39: 1 residues within 4Å:- Chain D: R.86
Ligand excluded by PLIPEDO.40: 4 residues within 4Å:- Chain B: T.393
- Chain D: R.297, Y.299, R.337
Ligand excluded by PLIPEDO.47: 10 residues within 4Å:- Chain E: A.167, G.215, I.216, G.217, P.218, C.222, T.224
- Chain H: Y.361
- Ligands: IMP.41, 8KY.42
Ligand excluded by PLIPEDO.48: 2 residues within 4Å:- Chain E: R.104, R.108
Ligand excluded by PLIPEDO.49: 1 residues within 4Å:- Chain E: R.86
Ligand excluded by PLIPEDO.50: 4 residues within 4Å:- Chain E: R.297, Y.299, R.337
- Chain H: T.393
Ligand excluded by PLIPEDO.57: 10 residues within 4Å:- Chain F: A.167, G.215, I.216, G.217, P.218, C.222, T.224
- Chain G: Y.361
- Ligands: IMP.51, 8KY.52
Ligand excluded by PLIPEDO.58: 2 residues within 4Å:- Chain F: R.104, R.108
Ligand excluded by PLIPEDO.59: 1 residues within 4Å:- Chain F: R.86
Ligand excluded by PLIPEDO.60: 4 residues within 4Å:- Chain F: R.297, Y.299, R.337
- Chain G: T.393
Ligand excluded by PLIPEDO.67: 10 residues within 4Å:- Chain E: Y.361
- Chain G: A.167, G.215, I.216, G.217, P.218, C.222, T.224
- Ligands: IMP.61, 8KY.62
Ligand excluded by PLIPEDO.68: 2 residues within 4Å:- Chain G: R.104, R.108
Ligand excluded by PLIPEDO.69: 1 residues within 4Å:- Chain G: R.86
Ligand excluded by PLIPEDO.70: 4 residues within 4Å:- Chain E: T.393
- Chain G: R.297, Y.299, R.337
Ligand excluded by PLIPEDO.77: 10 residues within 4Å:- Chain F: Y.361
- Chain H: A.167, G.215, I.216, G.217, P.218, C.222, T.224
- Ligands: IMP.71, 8KY.72
Ligand excluded by PLIPEDO.78: 2 residues within 4Å:- Chain H: R.104, R.108
Ligand excluded by PLIPEDO.79: 1 residues within 4Å:- Chain H: R.86
Ligand excluded by PLIPEDO.80: 4 residues within 4Å:- Chain F: T.393
- Chain H: R.297, Y.299, R.337
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kim, Y. et al., Crystal Structure of the Catalytic Domain of the Inosine Monophosphate Dehydrogenase fromCampylobacter jejuni in the complex with IMP and the inhibitor P225. To Be Published
- Release Date
- 2017-03-01
- Peptides
- Inosine-5'-monophosphate dehydrogenase: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.73 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x IMP: INOSINIC ACID(Non-covalent)
- 8 x 8KY: {2-chloro-5-[({2-[3-(prop-1-en-2-yl)phenyl]propan-2-yl}carbamoyl)amino]phenoxy}acetic acid(Non-covalent)
- 8 x K: POTASSIUM ION(Non-covalent)
- 24 x SO4: SULFATE ION(Non-functional Binders)
- 32 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kim, Y. et al., Crystal Structure of the Catalytic Domain of the Inosine Monophosphate Dehydrogenase fromCampylobacter jejuni in the complex with IMP and the inhibitor P225. To Be Published
- Release Date
- 2017-03-01
- Peptides
- Inosine-5'-monophosphate dehydrogenase: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A